https://ecancer.org/en/video/9743-bemarituzumab-with-folfox6-in-fgfr2b-advanced-gastric-gastroesophageal-junction-adenocarcinoma
Bemarituzumab with FOLFOX6 in FGFR2b+ advanced gastric/gastroesophageal junction adenocarcinoma -...
Prof Daniel Catenacci speaks to ecancer in an online interview for the virtual ASCO 2021 meeting about updates from the FIGHT study. Prof Cate
gastroesophageal junctionadvancedgastricadenocarcinoma